Achaogen Inc.

Achaogen Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$216.55 M
Shares Outstanding
45.21 M
Public Float
24.99 M


1 Tower Place
South San Francisco California 94080
United States
Employees -
Updated 09/14/2018
Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E.


View All

Kenneth J. Hillan
President & Director
Blake Wise
Chief Executive Officer & Director